These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16895848)

  • 1. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
    Zaghloul AA; Mustafa F; Siddiqui A; Khan M
    Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization.
    Zaghloul AA; Mustafa F; Siddiqu A; Khan M
    Drug Dev Ind Pharm; 2005 Sep; 31(8):803-11. PubMed ID: 16221615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of meloxicam in situ implant formulation by quality by design principle.
    Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
    Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.
    Zaghloul AA
    Pharmazie; 2006 Sep; 61(9):775-9. PubMed ID: 17020154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
    Arica B; Kaş HS; Orman MN; Hincal AA
    J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.
    Wang FJ; Wang CH
    J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
    Yadav KS; Sawant KK
    Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
    Iwata M; McGinity JW
    J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
    Haddadi A; Farboud ES; Erfan M; Aboofazeli R
    J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres.
    Sah H
    Int J Pharm; 2000 Feb; 195(1-2):103-13. PubMed ID: 10675688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design.
    Prakobvaitayakit M; Nimmannit U
    AAPS PharmSciTech; 2003 Dec; 4(4):E71. PubMed ID: 15198566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.